295 related articles for article (PubMed ID: 25318440)
1. Treating kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon by intralesional injection of absolute ethanol.
Shen W; Cui J; Chen J; Zou J; Xiaoying Z
J Craniofac Surg; 2014 Nov; 25(6):2188-91. PubMed ID: 25318440
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
3. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
Croteau SE; Gupta D
Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
[TBL] [Abstract][Full Text] [Related]
4. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
[TBL] [Abstract][Full Text] [Related]
5. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
[TBL] [Abstract][Full Text] [Related]
6. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
7. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.
Haisley-Royster C; Enjolras O; Frieden IJ; Garzon M; Lee M; Oranje A; de Laat PC; Madern GC; Gonzalez F; Frangoul H; Le Moine P; Prose NS; Adams DM
J Pediatr Hematol Oncol; 2002; 24(6):459-62. PubMed ID: 12218593
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
9. [Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
Korsaga-Somé N; Maruani A; Abdo I; Favrais G; Lorette G
Ann Dermatol Venereol; 2015 Oct; 142(10):578-80. PubMed ID: 25999262
[No Abstract] [Full Text] [Related]
10. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of Kasabach-Merritt phenomenon with intralesional corticosteroid injections: a case series.
Lee JJ; Lin LY; Hsieh SW; Chang TA; Jou ST; Liu CC; Chen MT
Ann Plast Surg; 2012 Dec; 69(6):627-32. PubMed ID: 23154333
[TBL] [Abstract][Full Text] [Related]
12. Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature.
Yuan SM; Shen WM; Chen HN; Hong ZJ; Jiang HQ
Int J Clin Exp Med; 2015; 8(6):10006-10. PubMed ID: 26309243
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of Kaposiform hemangioendothelioma.
Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
[TBL] [Abstract][Full Text] [Related]
14. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
Ji Y; Yang K; Peng S; Chen S; Xiang B; Xu Z; Li Y; Wang Q; Wang C; Xia C; Li L; Liu X; Lu G; Yang G; Wu H
Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome.
Brasanac D; Janic D; Boricic I; Jovanovic N; Dokmanovic L
Pathol Int; 2003 Sep; 53(9):627-31. PubMed ID: 14507321
[TBL] [Abstract][Full Text] [Related]
16. Kaposiform Haemangioendothelioma-spectrum Lesions with Kasabach-Merritt Phenomenon: Retrospective Analysis and Long-term Outcome.
Boccara O; Fraitag S; Lasne D; Fontaine J; Bughin V; Hamel-Teillac D; Orbach D; Brunelle F; de Prost Y; Hadj-Rabia S; Bodemer C
Acta Derm Venereol; 2016 Jan; 96(1):77-81. PubMed ID: 26084625
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
18. Treatment of kaposiform hemangioendothelioma and tufted angioma.
Liu XH; Li JY; Qu XH; Yan WL; Zhang L; Yang C; Zheng JW
Int J Cancer; 2016 Oct; 139(7):1658-66. PubMed ID: 27252149
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
20. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.
Chiu YE; Drolet BA; Blei F; Carcao M; Fangusaro J; Kelly ME; Krol A; Lofgren S; Mancini AJ; Metry DW; Recht M; Silverman RA; Tom WL; Pope E
Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
